Foresight Autonomous (FRSX) director discloses shares, options and RSUs

Rhea-AI Filing Summary

Foresight Autonomous Holdings Ltd. director Raz-Avayo Vered filed an initial statement of beneficial ownership. Vered directly holds 150,000 Ordinary Shares and stock options covering 42,857, 21,429 and 57,143 Ordinary Shares, each with an exercise price of $1.1200 per share.

The options expire on August 27, 2026, September 23, 2026 and October 20, 2029 and are fully vested. Vered also has 75,000 Ordinary Shares issuable upon vesting of restricted share units through July 1, 2027. The company’s securities are also listed as ADSs, where one ADS represents 90 Ordinary Shares.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Raz-Avayo Vered

Role Director

Type	Security	Shares	Price	Value
holding	Stock Options (Right to Buy)	--	--	--
holding	Stock Options (Right to Buy)	--	--	--
holding	Stock Options (Right to Buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (Right to Buy) — 42,857 shares (Direct); Ordinary Shares — 150,000 shares (Direct)

Footnotes (1)

1. Includes 75,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through July 1, 2027. Each RSU represents the right to receive one Ordinary Share. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on August 27,2017 and fully vested as of July 16, 2020. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on September 23 ,2019 and fully vested as of July 31, 2022. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on October 20 ,2022 and fully vested as of September 30,2025.

Key Figures

Direct Ordinary Shares: 150,000 shares Option Underlying Shares (2026-08-27): 42,857 shares Option Underlying Shares (2026-09-23): 21,429 shares +4 more

7 metrics

Direct Ordinary Shares 150,000 shares Directly held by Raz-Avayo Vered

Option Underlying Shares (2026-08-27) 42,857 shares Stock options, exercise price $1.1200, expiration August 27, 2026

Option Underlying Shares (2026-09-23) 21,429 shares Stock options, exercise price $1.1200, expiration September 23, 2026

Option Underlying Shares (2029-10-20) 57,143 shares Stock options, exercise price $1.1200, expiration October 20, 2029

Option Exercise Price $1.1200 per share Converted from NIS 3.50 using 3.119 ratio as of March 16, 2026

RSUs Outstanding 75,000 shares Ordinary Shares issuable upon RSU vesting through July 1, 2027

ADS to Ordinary Share Ratio 1 ADS = 90 Ordinary Shares ADS structure for issuer’s securities, convertible at holder’s election

Key Terms

restricted share units ("RSUs"), American Depository Shares ("ADS"), exercise price, fully vested, +1 more

5 terms

restricted share units ("RSUs") financial

"Includes 75,000 ordinary shares ... issuable upon the vesting of restricted share units ("RSUs") through July 1, 2027."

American Depository Shares ("ADS") financial

"The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares."

exercise price financial

"The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

fully vested financial

"The options were granted on October 20 ,2022 and fully vested as of September 30,2025."

expiration date financial

"The ADSs have no expiration date."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Raz-Avayo Vered

(Last) (First) (Middle)

C/O FORESIGHT AUTONOMOUS

7 GOLDA MEIR ISRAEL

(Street)

NESS ZIONA 7414001

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Foresight Autonomous Holdings Ltd. [ FRSX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	150,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(4)	08/27/2026	Ordinary Shares(2)	42,857	$1.12(3)	D
Stock Options (Right to Buy)	(6)	09/23/2026	Ordinary Shares	21,429	$1.12(5)	D
Stock Options (Right to Buy)	(8)	10/20/2029	Ordinary Shares	57,143	$1.12(7)	D

Explanation of Responses:

1. Includes 75,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through July 1, 2027. Each RSU represents the right to receive one Ordinary Share.

2. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.

3. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

4. The options were granted on August 27,2017 and fully vested as of July 16, 2020.

5. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

6. The options were granted on September 23 ,2019 and fully vested as of July 31, 2022.

7. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

8. The options were granted on October 20 ,2022 and fully vested as of September 30,2025.

	/s/ Vered Raz-Avayo	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Foresight Autonomous (FRSX) director Raz-Avayo Vered report owning?

Raz-Avayo Vered reports direct ownership of 150,000 Ordinary Shares plus vested stock options over additional shares. The filing also shows 75,000 Ordinary Shares issuable from RSUs that vest through July 1, 2027, indicating equity-based compensation exposure.

How many stock options does Raz-Avayo Vered hold in FRSX and at what price?

Vered holds stock options over 42,857, 21,429 and 57,143 Ordinary Shares. Each grant carries an exercise price of $1.1200 per share, converted from a NIS 3.50 grant price based on a stated 3.119 ratio as of March 16, 2026.

When do Raz-Avayo Vered’s Foresight Autonomous stock options expire?

The options held by Vered expire on August 27, 2026, September 23, 2026 and October 20, 2029. Footnotes state these options were granted in 2017, 2019 and 2022 and were fully vested by 2020, 2022 and 2025, respectively.

What RSU holdings does Raz-Avayo Vered have in Foresight Autonomous (FRSX)?

Vered holds restricted share units representing 75,000 Ordinary Shares, scheduled to vest through July 1, 2027. Each RSU converts into one Ordinary Share upon vesting, adding to Vered’s potential future share ownership beyond currently held shares and options.

How are Foresight Autonomous securities structured between Ordinary Shares and ADSs?

Foresight Autonomous securities are also listed as American Depository Shares (ADSs), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time at the holder’s election, and the ADSs have no expiration date according to the disclosure.

Is Raz-Avayo Vered’s Form 3 for FRSX reporting a transaction or just holdings?

This Form 3 functions as an initial statement of beneficial ownership, listing Vered’s existing holdings and derivative positions. The transactions are coded as holdings, with no buy or sell activity indicated, so it mainly documents the current equity position in the company.